Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Progressive Trend Toward Interventional Procedures Challenges Cardiac Surgery Devices Market - New analysis from Frost & Sullivan, U.S. Cardiac Surgery Devices Market finds that the number of CABG procedures performed in the United States to steadily decline, reaching to 223,036 procedures in 2013
Progressive Trend Toward Interventional Procedures Challenges Cardiac Surgery Devices Market

 

PRZOOM - /newswire/ - Palo Alto, CA, United States, 2007/08/21 - New analysis from Frost & Sullivan, U.S. Cardiac Surgery Devices Market finds that the number of CABG procedures performed in the United States to steadily decline, reaching to 223,036 procedures in 2013.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The national focus on cardiovascular health is all pervasive. Almost every supermarket and specialty food store has products promoting their benefits for the heart. Everything from cereals high in fiber to orange juice fortified with vitamins claim to reduce the risk of heart disease. Once considered bad due to their high fat content, meats, eggs, and cheese are currently marketed as part of a heart health diet in the context of a high protein low carbohydrate diet. Additionally, products such as aspirin are marketed to be beneficial to patients at risk for heart disease.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Cardiac Surgery Devices Market, then send an email to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, email address, city, state, and country. We will send you the information via email upon receipt of the above information.

New analysis from Frost & Sullivan (medicaldevices.frost.com), U.S. Cardiac Surgery Devices Market finds that the number of CABG procedures performed in the United States was 330,669 in 2006 and estimates that to steadily decline, reaching to 223,036 procedures in 2013.

Despite the warnings and growing awareness, obesity rates among adults and children are soaring. Statistics indicate the childhood obesity rate is around 16 percent, nearly double the rate it was in 1980. Nearly one in four deaths in the United States is due to cardiovascular disease, with nearly 1.2 million cases of heart attacks reported each year. There are six million people living with angina, which is chest pains due to narrowing blood vessels, and on average will require three to four repeat procedures throughout the rest of their lives. Current trends would indicate that future patients are likely to develop vascular diseases at a much younger age than previously witnessed.

Though alarming from a national health perspective, all of these statistics represent significant increases in the number of interventional vascular procedures performed and a strong future for the cardiovascular segment.
Thus, the cardiovascular sector of the medical device industry is the largest and most robust of any field in medical devices.

Advances in percutaneous coronary intervention (PCI), such as rapid exchange catheters, intravascular imaging, and the introduction of drug eluting stents, affects the usage rates of coronary artery bypass grafting (CABG). Furthermore, CABG is traditionally one of the most commonly performed surgical procedures in the United States. Although there are some concerns about the safety of drug eluting stents, healthcare facilities appear to favor minimally invasive alternatives over bypass grafting. With the entry of more sophisticated second and third generation drug eluting stents capable of addressing existing issues related to thrombosis and restenosis, the utilization of CABG procedures is likely to further decline.

“The cardiovascular sector of the medical device industry boasts of the highest research spending, sales, and reimbursement rates, “ says Frost & Sullivan Industry Analyst Venkat Rajan. “However, the dynamics of this sector are changing as newer technologies and devices gain precedence over older medical approaches.” Several major device manufacturers have shifted much of their research spending to PCI products over CABG-related ones, and even established leaders in cardiac surgery products are heavily promoting their new drug eluting stents. This has caused a corresponding shift in venture capital spending, with the focus increasingly moving toward PCI products due to their higher price points and greater market potential.

The two most critical concerns associated with any kind of procedure performed on the heart are accuracy and time. Outside of CABG procedures, there are a number of high growth sectors in the U.S. cardiac surgery market, such as surgical cardiac ablation. These newer advanced procedures require the highest level of precision and accuracy in order to witness even moderate levels of clinical efficiency. Recent advances in robotic-guided technology have the potential to drastically improve the success rates of cardiac ablation procedures and several robotic assist manufacturers are already eyeing the cardiac surgery market as a key area of focus.

With robotics, it is possible to directly translate the information from a 3-D mapping of the heart to a robot that could determine the exact location of the arrhythmia and the size of lesions required to treat it. This considerably improves both the time and accuracy of cardiac ablation procedures.

U.S. Cardiac Surgery Devices Market is part of the Medical Devices Subscription, which also includes research in the following markets: U.S. Carotid and Intracranial Devices, U.S. Cardiac Rhythm Management Market, and U.S. Congestive Heart Failure Devices market. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews with the press are available.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Progressive Trend Toward Interventional Procedures Challenges Cardiac Surgery Devices Market

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Melina Trevino 
210.247.2440 melina.trevino[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  RightITnow Ltd

Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today